Plains GP (NYSE:PAGP – Free Report) had its price objective boosted by Barclays from $18.00 to $19.00 in a report published on Thursday morning,Benzinga reports. The brokerage currently has an underweight rating on the pipeline company’s stock.
Several other research analysts also recently weighed in on the company. Morgan Stanley downgraded Plains GP from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $22.00 to $19.00 in a research note on Friday, October 25th. Wolfe Research upgraded Plains GP from a “peer perform” rating to an “outperform” rating and set a $22.00 price target on the stock in a research note on Friday, January 10th. Wells Fargo & Company downgraded shares of Plains GP from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $22.00 to $20.00 in a report on Wednesday, December 18th. Finally, StockNews.com upgraded shares of Plains GP from a “hold” rating to a “buy” rating in a research note on Friday, November 8th. Two analysts have rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $20.22.
Get Our Latest Stock Analysis on PAGP
Plains GP Trading Up 4.0 %
Plains GP Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Friday, January 31st will be issued a dividend of $0.38 per share. This is an increase from Plains GP’s previous quarterly dividend of $0.32. The ex-dividend date of this dividend is Friday, January 31st. This represents a $1.52 dividend on an annualized basis and a dividend yield of 7.07%. Plains GP’s payout ratio is 149.41%.
Institutional Investors Weigh In On Plains GP
A number of large investors have recently bought and sold shares of the company. Chickasaw Capital Management LLC lifted its stake in Plains GP by 24.7% during the 4th quarter. Chickasaw Capital Management LLC now owns 8,218,030 shares of the pipeline company’s stock valued at $151,047,000 after acquiring an additional 1,629,008 shares during the period. Thompson Siegel & Walmsley LLC purchased a new position in shares of Plains GP during the third quarter worth $13,848,000. Yaupon Capital Management LP purchased a new position in shares of Plains GP during the third quarter worth $9,772,000. Susquehanna Fundamental Investments LLC acquired a new position in Plains GP during the second quarter valued at $5,734,000. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Plains GP in the third quarter valued at $4,013,000. Hedge funds and other institutional investors own 88.30% of the company’s stock.
About Plains GP
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.
Read More
- Five stocks we like better than Plains GP
- Ride Out The Recession With These Dividend KingsĀ
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Energy and Oil Stocks Explained
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Trading Stocks: RSI and Why it’s Useful
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with MarketBeat.com's FREE daily email newsletter.